Mar 4, 2022
Feb 18, 2022
Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy
Feb 11, 2022
Feb 4, 2022
Diversity among our clinical trial participants can be measured along many dimensions, one of which is age
Jan 28, 2022
Registration for SWOG's spring 2022 hybrid group meeting opens Feb. 1